Sono‐Activatable Semiconducting Polymer Nanoreshapers Multiply Remodel Tumor Microenvironment for Potent Immunotherapy of Orthotopic Pancreatic Cancer
Advanced Science · 2023-12 · 10 (35)
DOI: 10.1002/advs.202305150 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 23.10.2023. Verfasst von Meng Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Biological Science and Medical Engineering, Donghua Univer…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Nanoparticles. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality, Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning.
Abstract (Originalsprache)
Due to the complicated tumor microenvironment that compromises the efficacies of various therapies, the effective treatment of pancreatic cancer remains a big challenge. Sono‐activatable semiconducting polymer nanoreshapers (SPN DN H) are constructed to multiply remodel tumor microenvironment of orthotopic pancreatic cancer for potent immunotherapy. SPN DN H contain a semiconducting polymer, hydrogen sulfide (H 2 S) donor, and indoleamine 2,3‐dioxygenase (IDO) inhibitor (NLG919), which are encapsulated by singlet oxygen ( 1 O 2 )‐responsive shells with modification of hyaluronidase (HAase). After accumulation in orthotopic pancreatic tumor sites, SPN DN H degrade the major content of tumor microenvironment hyaluronic acid to promote nanoparticle enrichment and immune cell infiltration, and also release H 2 S to relieve tumor hypoxia via inhibiting mitochondrion functions. Moreover, the relieved hypoxia enables amplified sonodynamic therapy (SDT) under ultrasound (US) irradiation with generation of 1 O 2 , which leads to immunogenic cell death (ICD) and destruction of 1 O 2 ‐responsive components to realize sono‐activatable NLG919 release for reversing IDO‐based immunosuppression. Through such a multiple remodeling mechanism, a potent antitumor immunological effect is triggered after SPN DN H‐based treatment. Therefore, the growths of orthotopic pancreatic tumors in mouse models are almost inhibited and tumor metastases are effectively restricted. This study offers a sono‐activatable nanoplatform to multiply remodel tumor microenvironment for effective and precise immunotherapy of deep‐tissue orthotopic tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Biological Science and Medical Engineering, Donghua University, Shanghai, 201620, China.
ORCID-Profile: Jingchao Li
Förderung
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
- Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning
Zitieren
APA
Li, M., Liu, Y., Zhang, Y., Yu, N., & Li, J. (2023). Sono‐Activatable Semiconducting Polymer Nanoreshapers Multiply Remodel Tumor Microenvironment for Potent Immunotherapy of Orthotopic Pancreatic Cancer. Advanced Science, 10(35). https://doi.org/10.1002/advs.202305150
Vancouver
Li M, Liu Y, Zhang Y, Yu N, Li J. Sono‐Activatable Semiconducting Polymer Nanoreshapers Multiply Remodel Tumor Microenvironment for Potent Immunotherapy of Orthotopic Pancreatic Cancer. Advanced Science. 2023;10(35). doi:10.1002/advs.202305150
BibTeX
@article{Li2023,
author = {Li, Meng and Liu, Yue and Zhang, Yijing and Yu, Ningyue and Li, Jingchao},
title = {Sono‐Activatable Semiconducting Polymer Nanoreshapers Multiply Remodel Tumor Microenvironment for Potent Immunotherapy of Orthotopic Pancreatic Cancer},
journal = {Advanced Science},
year = {2023},
volume = {10},
number = {35},
doi = {10.1002/advs.202305150}
}
EUVIMED